Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedNDA212304-001

ADLARITY(DONEPEZIL HYDROCHLORIDE)

Anticholinesterases

Manufacturer: CORIUM

FDA Approval: 11/03/2022

Route: TRANSDERMAL · SYSTEM

Active Ingredients

DONEPEZIL HYDROCHLORIDE 5MG/DAY

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ADLARITY — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.